AstraZeneca Signs Two Research Pacts | Chemical & Engineering News
Volume 91 Issue 43 | p. 17 | Concentrates
Issue Date: October 28, 2013

AstraZeneca Signs Two Research Pacts

Department: Business
Keywords: pharmaceutical, CRO, Taiwan, kidney, collaboration

AstraZeneca will team up on drug R&D with two organizations. German drug discovery firm Evotec will provide AstraZeneca with molecules that might be effective against chronic kidney diseases. AstraZeneca is making an up-front payment to Evotec and could make milestone payments. In Taiwan, AstraZeneca has joined with the National Research Program for Biopharmaceuticals, a government-funded drug discovery organization. NRPB will work with research groups in Taiwan to find alternative therapeutic uses for existing AstraZeneca compounds.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment